A Phase 1b Randomised, Open-Label, Dose Comparison Study Examining the Safety, Tolerability, and Efficacy of KB001 Antibody Mediated Oral Clearance of Porphyromonas gingivalis in Periodontitis (2023)
Experts
Professor
Saso Ivanovski
Head of School
Faculty of Health, Medicine and Behavioural Sciences